News
3 Q&A interviews with MVA-membersContact person
Below you will find a collection of 3 Q&A interviews with various MVA Members that we have made over the years.
3 Q&A interview with Jack Egelund, CEO, MedTech Bridge
What is the problem to which MedTech Bridge is the solution? For many ambitious European medtech companies, the US represents a significant commercial opportunity, but entering and scaling in the market requires the right expertise, relationships, and local understanding. At the same time,…
3 Q&A interview with CEO Fredrik Hultenius, QPharma
What sets QPharma apart as a CDMO, and which customer needs are we uniquely positioned to address? QPharma combines long-standing pharmaceutical manufacturing experience with specialized capabilities in high-potency drug products and controlled-release polymer-based drug delivery systems. We can…
3 Q&A interview with CEO, Peter Lindgren, IHE (The Swedish Institute for Health Economics)
How do you think The Swedish Institute for Health Economics – IHE – can contribute to the understanding and development of the Medicon Valley life science ecosystem? For more than 40 years, IHE has been a bridge builder between the different actors in the health care ecosystem. Through applied…
3 Q&A interview with Wim Verreth, Director Clinical Pharmacology Unit, new MVA member, SGS
Clinical research in Europe is evolving quickly. What are the biggest challenges sponsors are facing today? Many companies are not only racing against time. They are trying to reduce risk and uncertainty earlier. That is especially visible in biotech and pharma companies with promising science….
3 Q&A Interview with Håkan Brandt, General Manager at New MVA Member Beckhoff Automation
Which kind of problems does Beckhoff solve for the life science industry? Beckhoff supports the life science industry by solving challenges related to automation, flexibility, and efficiency in laboratory and production environments. Through advanced technologies such as XPlanar, XTS (eXtended…
3 Q&A Interview with Jens-Ole Bock, CEO and founder of new MVA member CRISPR Medicine News (CMN)
Jens-Ole Bock is a central figure in the European CRISPR landscape. As founder of CRISPR Medicine News (CMN), the CRISPRMED Conference series in Copenhagen, and the newly launched non-profit European Genomic Medicine Consortium (EGMEDC), he has spent more than two decades bridging the gap between…
3 Q&A interview with Malin Carlsson, co-founder TI-bridge Consulting
Why is Lund the right location for TI-bridge Consulting? Lund is a vibrant, small but international city. The fact that at every dog walk I take, I will meet someone I know, and I will hear ten different languages spoken in the streets. That is a unique combination. Lund University is World…
3 Q&A Interview with Lucian Jon, Operations Director – Denmark, MVA member NES Fircroft
What are the key elements of a successful recruitment process in the life science industry? At NES Fircroft, we believe that successful recruitment in the life science industry is built on deep sector knowledge, access to specialised talent, including strong local networks, and close, long-term…
3 Q&A with interview with Amar Fakhry, Founder and Senior Consultant, PharmaGroup ApS
What are your long-term goals and how do you expect to benefit from your new Medicon Valley Alliance membership? At PharmaGroup, our long-term focus is to strengthen compliance within Good Distribution Practice (GDP) across the life science sector in the Nordics and beyond. We aim to position…
3 Q&A with interview with Sofia Adolfsson, Scientific Officer, MVA member TATAA
How has the GLP accreditation changed the way you work at TATAA? Data quality has always been a central focus for us, but achieving GLP accreditation has elevated it to a new level. It strengthens all our services, supporting not only regulated bioanalysis but also biomarker studies such as…